Heterotrimeric guanine nucleotide-binding protein (G-protein)

Heterotrimeric guanine nucleotide-binding proteins (G-proteins) are essential molecular switches that relay signals from cell-surface G protein-coupled receptors (GPCRs) to intracellular effector proteins (StatPearls, 2023). They consist of three subunits: alpha (α), beta (β), and gamma (γ). In their inactive state, the alpha subunit binds GDP; upon receptor activation, GDP is exchanged for GTP, causing the complex to dissociate into Gα-GTP and Gβγ dimers (UniProt, 2024). Both components then modulate downstream targets like adenylyl cyclase or phospholipase C to initiate cellular responses (Wikipedia, 2024). These proteins play a critical role in various physiological processes, including sensory perception, cell growth, and hormonal response. Dysregulation or mutations in G-protein subunits are linked to numerous diseases, such as uveal melanoma (GNAQ/GNA11) and McCune-Albright syndrome (GNAS) (PubMed, 2022). While most therapeutic interventions target the upstream GPCRs, direct pharmacological modulation of G-proteins is an emerging area of drug development (PubChem, 2024). Specific inhibitors like YM-254890 demonstrate the potential for targeting these proteins directly in conditions driven by G-protein overactivity.

Other names

Heterotrimeric G proteinsG proteinsGuanine nucleotide-binding proteinsG-alpha-beta-gamma complex

Inhibition of GDP-GTP exchange, ADP-ribosylation of alpha subunits, and inhibition of G-beta-gamma subunit interactions with effectors.